Schedule 13G ownership disclosure

Seelos Therapeutics Inc (US)

Security class unavailable · CUSIP: 81577F406

Event date: 2024-11-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.7100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-24-004157
Form type
SC 13G/A
Filer
AdvisorShares Trust
CIK
CIK 1408970
Filed
Dec 04, 2024
Reporting period
Nov 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub